Genetic Architecture of Circulating Very-Long-Chain (C24:0 and C22:0) Ceramide Concentrations is a research paper published in Journal of Lipid and Atherosclerosis (2020). On theSindex it has a DataRank of 0.533. It has been cited 34 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.533
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: P20 HL113444
National Institutes of Health
Grant: P30 DK020579
National Institutes of Health
Grant: R34HL138253
National Institutes of Health
Grant: R21 HL145217
National Institutes of Health
Grant: R01 NR013396
National Institutes of Health
Grant: T32 GM074905
National Institutes of Health
Grant: N01-HL25195
National Institutes of Health
Grant: HHSN268201500001I
NHLBI NIH HHS
Grant: HHSN268201500001C
Foundation for Barnes-Jewish Hospital
Keywords
Additional file 1 of Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes
Additional file 1 of Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes
Additional file 2 of Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes
Additional file 2 of Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes
Additional file 3 of Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes
Additional file 3 of Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes
Additional file 6 of Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes
Additional file 6 of Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes
Additional file 4 of Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes
Additional file 5 of Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes
Additional file 5 of Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes
Additional file 4 of Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes